Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 5Phase 3 2

Status

Terminated 3Completed 3

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 3CNS 2Tumor-Agnostic 1

Conditions

Lymphoma 3Neoplasms 2Brain Neoplasms 2Spinal Cord Neoplasms 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Interventional × RRx-001 × Clear all
NCT01359982 2024-11-01

DINAMIC

EpicentRx, Inc.

Phase 1 Completed
26 enrolled 11 charts
Lymphoid

Lymphoma, Neoplasms

NCT04525014 2024-10-31

PIRATE

EpicentRx, Inc.

Phase 1 Terminated
2 enrolled
CNS

Brain Neoplasms, Neoplasms, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT02801097 2022-05-17

PAYLOAD

EpicentRx, Inc.

Phase 1 Terminated
28 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02215512 2021-11-03

BRAINSTORM

EpicentRx, Inc.

Phase 1 Completed
29 enrolled
CNS

Brain Neoplasms

NCT02518958 2019-11-18

PRIMETIME

EpicentRx, Inc.

Phase 1 Completed
12 enrolled
Lymphoid

Lymphoma

NCT02096341 2016-01-21

A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001

EpicentRx, Inc.

Phase 1 Terminated
2 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡